In an RCT of 93 patients with major depression and suicidal ideation on esketamine, adding 16 weeks of CBT vs usual care was feasible (72% completed); suicidal ideation (key secondary outcome) fell more with CBT, but suicide-related events did not differ.
RCTn = 93 patients
Wilkinson et al. Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention: The CBT-ENDURE Randomized Trial